Evaluation of genotoxic effects of fumagillin by sister chromatide exchange and chromosomal aberration tests in human cell cultures

Acta Veterinaria

Volumn 57, Issue 2-3, 2007, Pages 257-273

  Stanimirovic Z ^a   Ivana, Pejin I ^a   Kulisic Z ^a   Milanka, Djiporović ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Antiproliferative effect; Chromosome aberration (CA); Fumagillin; Genotoxicity; Sister chromatid exchange (SCE)

Indexed keywords

APIS MELLIFERA; APOIDEA; ASPERGILLUS FUMIGATUS; FUNGI;

EID: 34547326113     PISSN: 05678315     EISSN: None     Source Type: Journal    
DOI: 10.2298/AVB0703257S     Document Type: Article

References (82)

1. Agner G, Gyorbiro A, Valko I, Vasvari-Debreczy L, Szabo A, Farkas G et al., 2003, Light and temperature-induced degradation of fumagillin. Acta Pharm Hung, 73, 41-5.
2. Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F et al., 2000, IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans, Mutat Res, 463, 111-72.
3. Amitani R, Taylor G, Elezis EN, Llewellynjones C, Mitchell J, Kuze F et al., 1995, Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium, Infec Immun, 63, 3266-71.
4. Assil HI, Sporns P, 1991, ELISA and HPLC methods for analysis of fumagillin and its decomposition products in honey, J Agric Food Chem, 39, 2206-13.
5. Athanassopoulou F, Karagouni E, Dotsika E, Ragias V, Tavla J, Christofilloyanis P et al., 2004, Efficacy and toxicity of orally administrated anti-coccidial drugs for innovative treatments of Myxobolus sp. infection in Puntazzo puntazzo, Dis Aquat Organ, 62, 217-26.
6. Bailey L, 1953, Effect of fumagillin upon Nosema apis (Zander), Nature, 171, 212-3.
7. Bajic V, Stanimirovic Z, Stevanovic J, 2004, Genotoxicity potential of 8-Cl-Cyclic Adenosine Monophosphate Assessed with Cytogenetic Test in Vivo, Arch Med Res, 35, 209-14.
8. Barrett JC, Oshimura M, Tanaka N, Tsutsui T, 1985, Role of aneuploidy in early and late stages of neoplastic progression of Syrian hamster embryo cells in culture, Basic Life Sci, 36, 523-38.
9. Birch AJ, Hussain SF, 1969, Studies in relation to biosynthesis. Part 38. A preliminary study of fumagillin, J Chem Soc, 11, 1473-4.
10. Bünger J, Westphal G, Mönnich A, Hinnendahl B, Hallier E, Müller M, 2004, Cytotoxicity of occupationally and environmentally relevant mycotoxins, Toxicol, 202, 199-211.
11. Datta B, Majumdar A, Datta R, Balusu R, 2004, Treatment of Cells with the Angiogenic Inhibitor Fumagillin Results in Increased Stability of Eukaryotic Initiation Factor 2-Associated Glycoprotein, p67, and Reduced Phosphorylation of Extracellular Signal-Regulated Kinases, Biochem, 43, 14821-31.
12. Didier ES, 2005, Microsporidiosis: an emerging and opportunistic infection in humans and animals, Acta Trop 94, 61-76.
13. Didier ES, Bowers L, Stovall ME, Kuebler D, Mittleider D,. Brindley PJ et al., 2005, Antimicrosporidial activity of (fluoro)quinolones in vitro and in vivo, Folia parasit, 52, 173-81.
14. Djelic N, Djelic D, 2002, Enhanced sister-chromatid exchange rate in human lymphocytes exposed to 17 beta estradiol in vitro, Arch Med Res, 33, 148-51.
15. El-Matbouli M, Hoffmann RW, 1991, Prevention of experimentally induced whirling disease in rainbow trout Oncorhynchus mykiss by Fumagillin, Dis Aquat Organ 10, 109-13.
16. EMEA-The European Agency for the Evaluation of Medicinal Products, Veterinary Medicines and Information Technology, EMEA/CVMP/411/00-FINAL, Committee for Veterinary Medicinal Products, Update of the Position Paper on Availability of Veterinary Medicines agreed on 21 June 2000.
17. EMEA - The European Agency for the Evaluation of Medicinal Products, Pre-authorisation Evaluation of Medicines for Human Use, London, 22 January 2003, EMEA/COMP/82/02 Rev. 1. Committee for Orphan Medicinal Products, Public Summary of Positive Opinion for Orphan Designation of fumagillin for the treatment of diarrhoea associated with intestinal microsporidial infection.
18. Evans HJ, O'Riordan M, 1975, Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests, Mutat Res, 31, 135-48.
19. Fardis M, Pyun HJ, Tario J, Jin H, KimCU, Ruckman J et al., 2003, Design, synthesis and evaluation of a series of novel fumagillin analogues, Bioorg Med Chem, 11, 5051-8.
20. FDA Approved Animal Drug Products Online Database System Drug Product Abstract, http://meds.glowingpets.com/veterinary/2dawnk_9-23.html. Chapter 1.2 - Tradenames and Sponsors - Arranged by NADA Number: 009-252, Fumidil B, Mid-Continent Agrimarketing, Inc. 009-339, Carafen Cough, http://www.census.gov/ foreign-trade/schedules/b/2005/alpha-f.html.
21. Fucic A, Jazbec A, Mijic A, Seso-Simic D, Tomek R, 1998, Cytogenetic consequences after occupational exposure to antineoplasticdrugs, Mutat Res, 416, 59-66.
22. Furgala B, 1962, Residual fumagillin activity in sugar syrup stored by wintering honeybee colonies, J Apic Res, 1, 35-7.
23. Gilbert MA, Granath WO Jr, 2003, Whirling disease and salmonid fish: life cycle, biology, and disease, J Parasital, 89, 658-67.
24. Griffith EC, Su Z, Niwayama S, Ramsay CA, Chang YH, Liu JO, 1998, Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2, Proc Natl Acad Sci USA, 95, 15183-8.
25. Golden MC, Hahm SJ, Elessar RE, Saksonov S, Steinberg JJ, 1998, DNA damage by gliotoxin from Aspergillus fumigatus, Mycoses, 41, 97-104.
26. Hedrick RP, Groff JM, McDowell T, 1988, Oral administration of Fumagillin DCH protects Chinook salmon Oncorhynchus tshawytscha from experimentally-induced proliferative kidney disease, Dis Aquat Organ, 4, 165-8.
27. Heil J, Reifferscheid G, Waldmann P, Leyhausen G, Geurtsen W, 1996, Genotoxicity of dental materials, Mutat Res, 368, 181-94.
28. Hu T, Gibson DP, Carr GJ, Torontali SM, Tiesman JP, Chaney JG et al., 2004, Identification of a gene expression profile that discriminates indirect-acting genotoxins from direct-acting genotoxins, Mutat Res, 549, 5-27.
29. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H et al., 1990, Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth, Nature, 348, 555-7.
30. Ingelman-Sundberg M. 2001, Genetic variability in susceptibility and response to toxicants, Toxicol Lett, 120, 259-68.
31. I.P.S.C.. Guide to Short-term Tests for Detecting Mutagenic and Carcinogenic Chemicals, 1985, World Health Organization, Geneva.
32. Karagouni E, Athanassopoulou F, Lytra A, Komis C, Dotsika E, 2005, Antiparasitic and immunomodulatory effect of innovative treatments against Myxobolus sp. infection in Diplodus puntazzo, Vet Parasital, 134, 215-28.
33. Karbownik M, Reiter JJ, Cabrera J, García JJ, 2001, Comparison of the protective effect of melatonin with other antioxidants in the hamster kidney model of estradiol-induced DNA damage, Mutat Res, 474, 87-92.
34. Katznelson H, Jamieson CA, 1952, Control of Nosema disease of honey-bees with fumagillin, Science, 115, 70-1.
35. Keezer SM, Ivie SE, Krutzsch HC, Tandle A, Libutti SK, Roberts DD, 2003, Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin, Cancer Res. 63, 6405-12.
36. Kent ML, Dawe SC, 1994, Efficacy of fumagillin Dch# against experimentally-induced Loma salmonae (Microsporea) infections in chinook salmon Oncorhynchus tshawytscha, Dis Aquat Organ, 20, 231-3.
37. Killough JH, Magill GB, Smith RC, 1952, The treatment of amebiasis with fumagillin, Science. 115, 71-2.
38. Kochansky J, Nasr M, 2004, Laboratory studies on the photostability of fumagillin, the active ingredient of Fumidil B1, Apidologie, 35, 301-10.
39. Kulić M, Investigations of genotoxic potential od dicyclohexilamine in vivo and in vitro, 2006, PhD thesis, Department of Biology, University of Banja Luka.
40. Lamberti L, Bigatti-Ponzetto P, Ardito G, 1983, Cell kinetics and sister chromatid exchange frequency in human lymphocytes, Mutat Res, 120, 193-9.
41. Le Gouvello R, Pobel T, Richards RH, Gould C, 1999. Field efficacy of a 10-day treatment of fumagillin against proliferative kidney disease in rainbow trout Oncorhynchus mykiss. Aquaculture. 171, 27-40.
42. Lioi MB, Scarfi MR, Santoro A, Barbieri R, Zeni O, Di Berardino D et al., 1998, Genotoxicity and oxidative stress induced by pesticide exposure in bovine lymphocyte cultures in vitro. Mutat Res, 403, 13-20.
43. Lioi MB, Santoro A, Barbieri R, Salzano S, Ursini MV, 2004, Ochratoxin A and zearalenone: a comparative study on genotoxic effects and cell death induced in bovine lymphocytes, Mutat Res, 557, 19-27.
44. Liu S, Widom J, Kemp CW, Crews CM, Clardy J, 1998, Structure of human methionine aminopeptidase-2 complexed with fumagillin, Science. 282, 1324-7.
45. Liu TP, 1990a, Ultrastructure of mitochondria in the corpora allata of honeybees infected by Nosema apis before and after treatment with anti-Nosema drugs, Tissue Cell, 22, 511-5.
46. Liu TP, 1990b, Ultrastructural changes in the secretion granules of the hypopharyngeal glands of the honeybee infected by Nosema apis and after treatment with fumagillin, Tissue Cell, 22, 523-31.
47. Maluf SW, Erdtmann B, 2000, Follow-up study of the genetic damage in lymphocytes of pharmacists and nurses handling antineoplastic drugs evaluated by cytokinesis-block micronuclei analysis and single cell gel electrophoresis assay, Mutat Res, 471, 21-7.
48. Mazzanti CM, Tandle A, Lorang D, Costouros N, Roberts D, Bevilacqua G et al., 2004, Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells, Genome Res, 14, 1585-93.
49. McCowen MC, Callender ME, Lawlis JFJr, 1951, Fumagillin (H-3), a new antibiotic with amebicidal properties, Science, 113, 202-3.
50. Miller MC, Mohrenweiser HW, Bell DA, 2001, Genetic variability in susceptibility and response to toxicants, Toxicol Lett. 120, 269-80.
51. Mladjan V, Jovic M, 2000, Antibiotics in beekeeping, in: D. Trailovic, M. Lazarevic (Eds.), Proceedings of the 2nd Symposium in Animal Clinical Pathology and Therapy Clinica Veterinaria2000, Budva, 211-2.
52. Mladjan V, Todorovic D, Lolin M, 2000a, Preventive action of fumagillin on the degree of infection with Nosema apis in the digestive tract of bees, Acta Vet, 50, 241-52.
53. Mladjan V, Todorovic D, Lolin M, 2000b, Therapeutic effects of fumagillin and first appearance of Nosema apis spores following infection, Acta Vet, 50, 253-62.
54. Mohrenweiser HW, Jones IM, 1998, Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? Mutat Res, 400, 15-24.
55. Molina JM, Goguel J, Sarfati C, Michiels JF, Desportes-Livage I, Balkan S et al., 2000, Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection, AIDS, 14, 1341-8.
56. Molina JM, Tourneur M, Sarfati C, Chevret S, de Gouvello A, Gobert JG et al., F, 2002, Fumagillin treatment of intestinal microsporidiosis, N Engl J Med, 346 (2002) 1963-9.
57. Morris DJ, Adams A, Smith P, Richards RH, 2003, Effects of oral treatment with TNP-470 on rainbow trout (Oncorhynchus mykiss) infected with Tetracapsuloides bryosalmonae (Malacosporea), the causative agent of proliferative kidney disease, Aquaculture, 221, 51-64.
58. Mortelmans K, Haworth S, Lawlor T, Speck W, Tainer B, Zeiger E, 1986, Salmonella mutagenicity tests: II. Results from testing of 270 chemicals, Environ Mutagen, 8, Suppl 7, 1-119.
59. Nieminen SM, Maki-Paakkanen J, Hirvonen MR, Roponen M, von Wright A, 2002, Genotoxicity of gliotoxin, a secondary metabolite of Aspergillus fumigatus, in a battery of short-term test systems, Mutat Res, 520, 161-70.
60. Norppa H, 2003, Cytogenetic biomarkers and genetic polymorphisms, Toxicol Lett, 144, 25.
61. Oshimura M, Barrett JC, 1986, Chemically induced aneuploidy in mammalian cells: mechanisms and biological significance in cancer, Environ Mutagen 8, 129-59.
62. Perry P, Wolff S, 1974, New Giemsa method for the differential staining of sister chromatids, Nature, 251, 56-158.
63. Purchase IFH, Longstaff E, Ashby J, Styles JA, Anderson D, Lefevre PA et al., 1978, An evaluation of 6 short-term tests for detecting organic chemical carcinogens, Br J Cancer, 37, 873-959.
64. Rada V, Machova M, Huk J, Marounek M, Duskova D, 1997, Microflora in the honeybee digestive tract - counts, characteristics and sensitivity to veterinary drugs, Apidologie, 28, 357-65.
65. Ronne M, 1991, High resolution banding present aspects, Gen Sel Evol, 23, 1, 49-55.
66. Roserger DF, Serdaravic ON, Evlandson RA, Bryan RT, Schwartz DA, Visvesvara GS et al., 1993, Successful treatment of microsporidial keratoconjunctivitis with topical fumagillin in a patient with AIDS, Cornea, 12, 261-5.
67. Sabater-Vilar M, Nijmeijer S, Fink-Gremmels J, 2003, Genotoxicity assessment of five tremorgenic mycotoxins (fumitremorgen B, paxilline, penitrem A, verruculogen, and verrucosidin) produced by molds isolated from fermented meats, J Food Prot, 66, 2123-9.
68. Schmid W, 1975, The micronucleus test, Mutat Res, 31, 9-15.
69. Seabright M, 1971, A rapid banding technique for human chromosomes, Lancet, 2, 971-2.
70. Shadduck JA, 1980, Effect of fumagillin on in vitro multiplication of Encephalitozoon cuniculi, J Protozool 27, 202-28.
71. Sin N, Meng L, Wang MQ, Wen JJ, Bornmann WG, Crews CM, 1997, The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci USA, 94, 6099-103.
72. Stanimirovic Z, Stevanovic J, Pejovic D, 1999, Analysis of genotoxic effects of fumagillin-ET, In: Proceedings of the 29th Annual Meeting of the European Environmental Mutagen Society-EEMS-99, vol. 85, Copenhagen, 44-5.
73. Stanimirovic Z, Stevanovic J, Jovanovic S, Andjelkovic M, 2005, Evaluation of genotoxic effects of Apitol® (cymiazole hydrochloride) in vitro by measurement of sister chromatid exchange, Mutat Res, 588, 152-7.
74. Stevanovic J, Stanimirovic Z, Djelic N, Djurkovic Snezana, 2000, Is the application of fumagillin in nosemosis treatment acceptable from a genotoxicological point of view. In: Trailovic D, Lazarevic M, editors, Proceedings of the 2nd Symposium in Animal Clinical Pathology and Therapy Clinica Veterinaria2ooo- June 12-16, Budva, 227-30.
75. Stoltz DR, Khera KS, Bendall R, Gunner SW, 1970, Cytogenetic studies with cyclamate and related compounds, Science, 167, 1501-2.
76. Tucker D, Auletta A, Cimino MC, Dearfield KL, Jacobson-Kram D, Tice RR et al., 1993, Sister chromatid exchange: second report of gene-tox program, Mutat Res, 197, 101-80.
77. Tucker JD, Preston RJ, 1996, Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges, and cancer risk assessment, Mutat Res, 365, 147-59.
78. Wang J, Lou P, Henkin J, 2000, Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases, J Cell Biochem, 77, 465-73.
79. Whittington R, Winston ML, 2003, Effects of Nosema bombi and its treatment fumagillin on bumble bee (Bombus occidentalis) colonies, J Invertebr Pathol, 84, 54-8.
80. Wilkins JH, Joshi N, Margolis TP, Cevallos V, Dawson DR, 1994, Vlicrosporidial keratoconjunctivitis treated successfully with a short course of fumagillin, Eye, 8, 703-4.
81. Zbinden M, Lass S, Refardt D, Hottinger J, Ebert D, 2005, Octosporea bayeri: fumidil B inhibits vertical transmission in Daphnia magna, Exp Parasitol 109, 58-61.
82. Zimonjic DB, Savkovic N, Andjelkovic M, 1990, Genotoxic agents: the effects, principles and methodology of detection. Naucna knjiga, Beograd, 1-395.